ITMCTR2026001722进行中（未招募）Unknown
Development and Efficacy Evaluation of Standardized Diagnostic Scales for FeirePishi Syndrome in Allergic Rhinitis: A Delphi Method Study
Beijing Tongren Hospital Affiliated to Capital Medical University0 个研究点开始时间: 2026年8月31日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •for the Feirepishi Pattern group:Aged 18–65 years, of either sex;Diagnosed with allergic rhinitis (AR) according to the Chinese Guidelines for the Diagnosis and Treatment of Allergic Rhinitis (2022, Revised Edition);Meet the traditional Chinese medicine (TCM) diagnostic criteria for the Feirepishi Pattern;Willing to comply with all study procedures and provide written informed consent.Inclusion criteria for the non-Feirepishi Pattern group:Aged 18–65 years, of either sex;Diagnosed with AR according to the same guidelines;Do not meet the TCM diagnostic criteria for the Feirepishi Pattern;Willing to comply with all study procedures and provide written informed consent.
排除标准
- •Individuals with other severe nasal diseases, such as purulent sinusitis, severe nasal polyps, severe nasal septum deviation or curvature, and nasal cavity tumors; those with concurrent asthma attacks; individuals who have had severe primary diseases in the cardiovascular, cerebrovascular, liver, kidney, and hematopoietic systems within the past six months; pregnant women, lactating women, or women planning to become pregnant; those who do not meet the inclusion criteria and other situations unsuitable for enrollment.
研究者
相似试验
尚未招募
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared with Placebo in Adults with Type 2 Diabetes Mellitus on
Background Insulin (Eluminate-3)Type 2 Diabetes MellitusjRCT203126026280
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron and Dapagliflozin in Combination, Compared With Elecoglipron Alone and Dapagliflozin Alone, in Adults With Type 2 Diabetes Mellitus (Eluminate-5)Type 2 Diabetes MellitusjRCT2031260261165
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin (Eluminate-4)Type 2 Diabetes Mellitus and Impaired Renal FunctionjRCT2031260268118
尚未招募
不适用
A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)Renal Insufficiency, ChronicjRCT2031260364200
招募中
不适用
A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus (Eluminate-1)Type 2 Diabetes MellitusjRCT203126027880